Parents of HAE-C1-INH patients who are carriers of germline SERPING1 mutations have a recurrence risk of 50%, whereas patients with true de novo mutations have a recurrence risk similar to that of the general population (negligible in terms of genetic counseling). Here, SERPING1 is linked to hereditary angioedema.